Crystalline Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Crystalline Management’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,063,056	Closed	-$1.02M	–	151
2023 Q2	$1.02M	Buy	+1,063,056	New	+$1.05M	0.72%	47

Crystalline Management's SPPI Position: Q3 2023 in Review

Crystalline Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q3 2023, closing a stake of 1,063,056 shares — an estimated $1.02M sold.

Crystalline Management first reported a position in SPPI in Q2 2023 and held it in 1 quarter. The position peaked at $1.02M in Q2 2023. 0 funds tracked by Wall St. Rank hold SPPI as of Q3 2023.

Crystalline Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q3 2023 after selling out during the quarter.
Crystalline Management sold 1,063,056 Spectrum Pharmaceuticals Inc shares in Q3 2023, an estimated $1.02M.
Crystalline Management first reported a position in Spectrum Pharmaceuticals Inc in Q2 2023 and held it in 1 quarter.
Crystalline Management's Spectrum Pharmaceuticals Inc position peaked at $1.02M in Q2 2023.
0 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q3 2023.

Based on Crystalline Management's 13F filing for Q3 2023, filed 13 Nov 2023.